Marvin & Palmer Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$3.3M |
| 2 |
PayPal
PYPL
|
+$3.28M |
| 3 |
Adobe
ADBE
|
+$2.49M |
| 4 |
Cigna
CI
|
+$2.3M |
| 5 |
Hilton Worldwide
HLT
|
+$2.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$5.75M |
| 2 |
Zions Bancorporation
ZION
|
+$4.75M |
| 3 |
Union Pacific
UNP
|
+$4.64M |
| 4 |
Comcast
CMCSA
|
+$4.11M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$4.09M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.87% |
| 2 | Technology | 23.5% |
| 3 | Healthcare | 13.86% |
| 4 | Industrials | 12.1% |
| 5 | Communication Services | 4.02% |
Similar funds
Marvin & Palmer Associates's Q3 2017 Portfolio in Review
As of Q3 2017, Marvin & Palmer Associates held 46 positions worth $81.4M, down 38% from $132M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Marvin & Palmer Associates withdrew a net $58.1M in Q3 2017, closing 7 positions and reducing 23 holdings. Its most notable exit was Zions Bancorporation, an estimated $4.75M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 32% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Marvin & Palmer Associates opened a new position in Celgene Corp worth $3.54M.
- Marvin & Palmer Associates's largest Q3 2017 buy was Celgene Corp: 24,260 shares worth $3.54M.
- Marvin & Palmer Associates added most to iShares MSCI Germany ETF in Q3 2017, an estimated $56.4K increase.
- Marvin & Palmer Associates's biggest Q3 2017 reduction was Amazon, cutting an estimated $5.75M.
- Marvin & Palmer Associates fully exited Zions Bancorporation in Q3 2017, selling an estimated $4.75M.
- Marvin & Palmer Associates's ten largest holdings make up 46% of its $81.4M portfolio in Q3 2017.
- Marvin & Palmer Associates opened 14 new positions and closed 7 in Q3 2017.
- Marvin & Palmer Associates's portfolio value fell 38% quarter-over-quarter to $81.4M.
Based on Marvin & Palmer Associates's 13F filing for Q3 2017, filed 9 Nov 2017.